Condition: Diabetes Mellitus, Type 2 · Nicotine Addiction · Tobacco Dependence · Sponsor: Ottawa Heart Institute Research Corporation
To assess the feasibility of conducting a randomized controlled trial (RCT) to determine the effectiveness of semaglutide as an adjunct to combination NRT in supporting smoking cessation for patients with diabetes.
This description comes directly from the study's public registry record.
Evyanne Quirouette · 613-696-7000 · equirouette@ottawaheart.ca
Nidhi Agrawal · 613-696-7000 · NAgrawal@ottawaheart.ca
Always discuss trial participation with your own doctor first.
| University of Ottawa Heart Institute | Ottawa, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07059377